Expression of SLC10A1 in rat cholangiocarcinoma tissues is reduced, and this is related to the proliferation phenotype of cholangiocarcinoma, which may be one of the therapeutic targets of cholangiocarcinoma33. This evidence concerns the gene SLC10A1 and cholangiocarcinoma.